TSLP Monoclonal Antibody Market: Rising Severe Asthma Treatment...

added blog Wellness

2026-07-30 12:13:24 -

TSLP Monoclonal Antibody Market: Rising Severe Asthma Treatment Adoption, Expanding Biologic Therapy Pipeline, and Growing Investment in Type 2 Inflammation Targeted Treatments Driving Market Expansion

The TSLP Monoclonal Antibody Market is experiencing significant growth as adoption of severe asthma treatments increases, the biologic therapy pipeline expands, and investment in type 2 inflammation targeted treatments continues to rise. The global market was valued at approximately USD 250–650 million in 2024 and is projected to reach between USD 4.8 billion and USD 22.45 billion by...

0 Comments 0 Shares 93 Views 0 Reviews